stockrowAllogene Therapeutics, Inc. (ALLO) vs Editas Medicine, Inc. (EDIT)
- Allogene Therapeutics, Inc. ALLO 1.04 −4.59%
- Editas Medicine, Inc. EDIT 2.57 +0.78%
Allogene Therapeutics, Inc. and Editas Medicine, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Editas Medicine, Inc. are of similar size ($391.6M and $376.6M). Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against 20.8%. Editas Medicine, Inc. has the higher net margin (−157.3% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 15 metrics below, Editas Medicine, Inc. leads on 8 and Allogene Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ALLO | EDIT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (3,832.45%) | (161.39%) | 0.00% |
| Net margin | (3,517.41%) | (157.32%) | 0.00% |
| Free cash flow margin | (2,180.62%) | (255.88%) | 0.00% |
| Return on equity | (42.39%) | (118.82%) | (51.96%) |
| Return on assets | (32.43%) | (33.02%) | (46.06%) |
| Return on invested capital | (108.81%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack